EnBiotix is Drug Discovery in United States that focus on tuberculosis mycobacterial infections business. Founded in 2010. They cover business area such as operator, therapy, drug-resistant bacterial infection, cystic fibrosis, non-cf bronchiectasis, non-tuberculosis mycobacterial infection, patient, treatment, chronic, recurrent, and life-threaten pulmonary infection.
2010
( 14 years old in 2024 )
Tuberculosis Mycobacterial Infections
-
197 West Springfield Street
Boston, MA 02118
United States
Private
operatortherapydrug-resistant bacterial infectioncystic fibrosisnon-cf bronchiectasisnon-tuberculosis mycobacterial infectionpatienttreatmentchronic, recurrent, and life-threaten pulmonary infection
* We use standard office opening hours in near EnBiotix's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
EnBiotix is Drug Discovery business from United States that founded in 2010 (14 years old in 2024), EnBiotix business is focusing on Tuberculosis Mycobacterial Infections.
EnBiotix headquarter office and corporate office address is located in 197 West Springfield Street Boston, MA 02118 United States.
EnBiotix was founded in United States.
In 2024, EnBiotix is currently focus on tuberculosis mycobacterial infections sector.
Above is snippet of Google Trends for "tuberculosis mycobacterial infections" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with EnBiotix, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
